Search & Analyze

Caplin Point Laboratories Ltd.

2,336.40−37.20 (−1.57%)

BSE · 30 Oct, 4:01 PM

: ₹17,671.58 Cr
: 26.56
: 5,703
: ₹2,422.70 - ₹2,308.75
: ₹2,990.60 - ₹1,502.45

Caplin Point Laboratories Ltd. (CAPLIPOINT) share price closed at ₹2,336.40 on the BSE on Friday, October 30, 2026, down by 1.57% from its of ₹2,373.60. In that session CAPLIPOINT reached a of 2,422.70 and of 2,308.75. The for the session was 2,352.89. The stands at 2,568.71 and is at 2,162.09. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹2,391.25

₹2,373.60

₹2,352.89

₹2,568.71

Price 9.04% below

₹2,162.09

Price 8.06% above

Key Fundamentals

: 17,671.58 Cr₹17.67 Thousand Crore
: 87.53
: 26.56
: 4.81
: 483.17
: 922.54 Cr₹922.54 Crore
: 0.34 %
Sector
Industry: Pharmaceuticals & Drugs
: 20.79
: 0.00

Industry Comparison

Ratio	Company	Sector
	26.56	44.77
	0.00	0.20
	4.81	4.61
	6.70	1.81
	0.34 %	0.11 %
Operating Margin	34.79 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	38.91	4,26,661.74	0.90	1,995.07	-36.16%	16,198.71	11.88%	19.11
DIVI'S LAB. DIVISLAB	9,715.00	88.17	2,57,902.73	0.31	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,635.15	83.01	1,76,306.21	0.82	534.00	-9.64%	4,979.00	50.79%	19.27
LAURUSLABS LAURUSLABS	2,392.00	96.46	1,29,242.68	0.08	436.19	124.27%	2,206.37	33.44%	18.20
ZYDUSLIFE ZYDUSLIFE	1,244.00	27.50	1,24,089.48	0.08	990.20	-34.90%	8,017.00	21.96%	21.39
DR.REDDY'S DRREDDY	1,350.20	40.25	1,12,698.53	0.59	913.20	-31.69%	8,697.80	-1.48%	13.75
CIPLA LTD. CIPLA	1,380.00	38.48	1,11,488.55	0.94	851.51	-37.08%	7,403.93	-2.44%	16.00
Caplin Point Laboratories Ltd. CAPLIPOINT	2,336.40	26.56	17,671.58	0.34	179.09	18.79%	610.36	19.63%	24.97

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	453.22	458.96	483.10	492.96	502.45	510.22	534.04	542.77	600.16	610.36
Expenses	307.99	307.15	318.34	330.67	334.39	332.46	344.87	353.08	395.92	396.88
	145.23	151.81	164.76	162.29	168.06	177.76	189.17	189.69	204.24	213.48
	32.04%	33.08%	34.10%	32.92%	33.45%	34.84%	35.42%	34.95%	34.03%	34.98%
	17.29	18.56	20.77	31.36	25.74	23.14	30.37	33.68	28.36	33.55
Interest	0.15	0.05	0.21	0.18	0.17	0.18	0.16	0.18	0.36	0.18
	16.40	15.96	16.76	16.20	17.04	16.29	18.40	19.28	18.80	21.62
	146.03	154.38	168.46	177.26	176.67	184.46	201.00	203.89	213.44	225.22
	16.98%	19.08%	22.35%	20.98%	17.77%	18.27%	20.28%	18.65%	19.00%	20.48%
	121.59	123.97	130.80	138.96	142.57	152.80	154.45	163.88	170.11	176.91
	16.01	16.31	17.21	18.28	18.76	20.11	20.32	21.56	22.38	23.28

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	1,269.41	1,466.73	1,694.10	1,937.47	2,187.19
	1,269.41	1,466.73	1,694.10	1,937.47	2,187.19
EXPENDITURE :
Increase/Decrease in Stock	-31.92	-46.94	-42.70	38.56	-63.72
Raw Material Consumed	589.43	710.15	766.88	732.28	929.40
Power & Fuel Cost	21.40	25.53	33.57	37.83	37.38
Employee Cost	114.74	136.12	142.66	184.06	198.58
Other Manufacturing Expenses	82.01	90.99	117.73	120.13	132.06
General and Administration Expenses	66.68	85.38	92.97	112.05	126.61
Selling and Distribution Expenses	27.52	18.78	24.88	55.34	53.35
Miscellaneous Expenses	5.02	6.20	6.67	10.29	12.68
	874.88	1,026.21	1,142.66	1,290.54	1,426.34
Operating Profit (Excl OI)	394.53	440.52	551.44	646.93	760.85
	38.89	56.52	66.94	96.43	115.54
	433.42	497.04	618.38	743.36	876.39
Interest	0.70	0.78	0.78	0.61	0.87
PBDT	432.72	496.26	617.60	742.75	875.52
	46.90	44.99	53.44	65.96	72.77
Profit Before Taxation & Exceptional Items	385.82	451.27	564.16	676.79	802.75
	385.82	451.35	564.43	676.78	802.79
Provision for Tax	77.37	74.36	103.01	135.69	153.06
	308.45	376.99	461.42	541.09	649.73
Extra items				0.00	0.00
Minority Interest	-8.61	-0.73	-4.33	-4.78	-8.49
Consolidated Net Profit	299.84	376.26	457.09	536.31	641.24
Profit Balance B/F	914.41	1,191.20	1,539.79	1,962.71	2,368.96
Appropriations	1,214.25	1,567.46	1,996.88	2,499.02	3,010.20
Equity Dividend %	200.00%	225.00%	250.00%	300.00%	400.00%
	39.56	49.57	60.18	70.57	84.37
Adjusted EPS	39.56	49.57	60.18	70.57	84.37

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	89.74	89.76	89.77	89.78	89.78
Share Warrants & Outstandings	15.45	15.37	14.22	19.65	18.30
Total Reserves	1,378.74	1,775.35	2,211.72	2,741.06	3,478.34
Reserve excluding Revaluation Reserve	1,378.74	1,775.35	2,211.72	2,741.06	3,478.34
Revaluation reserve			0.00
	1,483.93	1,880.48	2,315.71	2,850.49	3,586.42
Minority Interest	25.95	26.79	31.12	35.90	44.38
Deferred Tax Assets / Liabilities	-6.21	-14.00	-12.55	-2.23	4.63
Other Long Term Liabilities	10.28	8.35	11.40	13.73	15.12
Long Term Provisions	8.48	7.78	9.04	1.74	1.00
Total Non-Current Liabilities	12.55	2.13	7.89	13.24	20.75
Trade Payables	155.94	152.56	229.62	217.58	296.03
Other Current Liabilities	48.68	99.94	90.29	64.28	69.34
Short Term Borrowings	0.50	3.41	0.28	0.55	0.57
Short Term Provisions	2.56	12.09	10.66	23.58	20.02
Total Current Liabilities	207.68	268.00	330.85	305.99	385.96
Total Liabilities	1,730.11	2,177.40	2,685.57	3,205.62	4,037.51
Gross Block	445.74	480.32	702.31	859.07	964.68
Less: Accumulated Depreciation	159.17	200.51	249.65	313.29	384.67
	286.57	279.81	452.66	545.78	580.01
	15.41	220.48	116.62	139.22	208.62
Non Current Investments	37.01	70.52	137.63	279.13	473.31
Long Term Investment	37.01	70.52	137.63	279.13	473.31
Long Term Loans & Advances	89.90	51.51	78.31	88.61	151.11
Other Non Current Assets	1.08	2.66	7.43	14.65	13.84
Total Non-Current Assets	432.29	625.21	792.65	1,071.67	1,451.85
Currents Investments	51.97	210.18	237.98	311.33	385.71
Inventories	227.31	288.22	363.04	336.10	428.86
Sundry Debtors	317.05	394.06	542.72	632.49	825.81
Cash and Bank	462.99	493.48	552.74	591.41	621.04
Other Current Assets	13.61	22.82	50.43	77.11	97.92
Short Term Loans and Advances	224.89	143.43	146.01	185.51	226.32
Total Current Assets	1,297.82	1,552.19	1,892.92	2,133.95	2,585.66
Net Current Assets (Including Current Investments)	1,090.14	1,284.19	1,562.07	1,827.96	2,199.70
Total Assets	1,730.11	2,177.40	2,685.57	3,205.62	4,037.51
	0.71	0.64	0.64	0.64	17.53
Total Debt	0.50	3.41	0.28	0.55	0.57
	183.89	235.91	293.21	362.67	459.68
Adjusted Book Value	183.89	235.91	293.21	362.67	459.68

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	385.82	451.35	564.43	676.78	802.79
Adjustment	30.44	11.77	2.40	5.51	-26.08
Changes In working Capital	1.96	-103.75	-139.44	-122.28	-108.97
Cash Flow after changes in Working Capital	418.22	359.37	427.39	560.01	667.74
Cash Flow from Operating Activities	336.73	271.37	318.39	432.37	523.24
Cash Flow from Investing Activities	-376.77	-217.58	-320.04	-334.73	-582.30
Cash Flow from Financing Activitie	-40.68	-28.17	-38.07	-38.32	-46.46
Net Cash Inflow / Outflow	-80.72	25.62	-39.72	59.32	-105.52
Opening Cash & Cash Equivalents	231.57	150.76	177.56	138.70	199.45
Cash & Cash Equivalent on Amalgamation / Take over / Merger		-6.64	-4.50	-5.71	-7.54
Effect of Foreign Exchange Fluctuations	-0.09	1.18	0.86	1.43	0.25
Closing Cash & Cash Equivalent	150.76	170.92	134.20	193.74	86.64

Ratios

Valuation

26.56

4.81

18.48

7.73

87.53

483.17

Profitability

20.79

24.97

17.94

34.79

29.71

Leverage & Liquidity

0.00

6.70

923.75

Returns

0.34

0.60

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	70.56	70.56	70.56	70.56	70.56	70.57	70.57	70.57	70.57	70.57
	4.86	5.53	6.97	7.74	8.39	8.61	8.64	8.29	8.24	7.93
	24.57	23.91	22.47	21.70	21.05	20.82	20.79	21.14	21.18	21.50
	29.44	29.44	29.44	29.44	29.44	29.43	29.43	29.43	29.43	29.43
No. of Shareholders	80,411	96,123	92,702	96,387	94,169	93,753	93,705	93,896	94,385	1,03,386

Mutual Funds Invested(64)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 10 active funds hold 1.42% in Caplin Point Laboratories Ltd., contributing to ₹294 Cr of holdings

Fund				As of
UT UTI Small Cap Fund - Growth - Direct PlanSmall cap Fund	98.03	1.87	3,60,882	Sep '26
UT UTI Large & Mid Cap Fund - Growth - Direct PlanLarge & Mid Cap	67.43	1.08	2,48,238	Sep '26
UT UTI Aggressive Hybrid Fund - Growth - Direct PlanHybrid - Aggressive Hybrid Fund	51.94	0.80	1,91,227	Sep '26
UT UTI Healthcare Fund - Growth - Direct PlanPharma & Health Care	43.20	3.02	1,59,030	Sep '26
UT UTI Retirement Fund - Direct PlanDebt Oriented	21.63	0.47	79,628	Sep '26
NI Nippon India Nifty Smallcap 250 Index Fund - Growth - Direct PlanIndex Funds - Other	8.43	0.24	31,032	Sep '26
MI Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETFIndex	6.64	0.71	24,442	Sep '26
HD HDFC NIFTY Smallcap 250 ETFIndex	6.62	0.24	24,355	Sep '26
QU Quantum Small Cap Fund - Growth - Direct PlanSmall cap Fund	4.50	1.72	16,572	Sep '26
SB SBI Nifty Smallcap 250 Index Fund - Growth - Direct PlanIndex Funds - Other	4.28	0.24	15,764	Sep '26

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-08-21	AGM
2026-08-12	Ex Dividend	Rs.4.0000 per share(200%)Final Dividend	2026-09-18	2026-09-18
2026-07-29	Board Meeting	Quarterly Results & Final Dividend

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Caplin Point Laboratories Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

10 members across the board and senior leadership

C C Paarthipan

Chairman

—

Ashok Partheeban

Vice Chairman

—

Vivek Partheeban

Vice Chairman

₹12.49 L

Mar '26

Sridhar Ganesan

Managing Director

₹57.00 L

Mar '26

R Nagendran